Catheters Developed by Dr. Riyaz Bashir Garner Media Attention

The U.S. Food and Drug Administration granted premarket notification clearance for two catheters originally developed by Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital; and Nicholas Green, Director of Research and Development at Thrombolex, Inc. The announcement received coverage from Endovascular Today, Scienmag and Bioengineer.org.